Showing results (711-720 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|October 28, 2024
A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastasesJose Carrillo, Jaya Mini Gill, Charles Redfern, et al.
Neuro-Oncology Advances|October 1, 2025
Global insights into brain tumor registries: Lessons for countries establishing a national brain tumor registryHolly Wilson, Chris Tse, Sandar Tin Tin, et al.
Neuro-Oncology Advances|September 22, 2025
Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?Montse Alemany, Jordi Bruna, Victor J Yuste
Neuro-Oncology Advances|September 22, 2025
Assessment of the emerging role of AI in diagnosing gliomas using MRI: Systematic review and meta-analysisAmirah Alsaedi, Walaa Alsharif, Awadia Gareeballah, et al.
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Neuro-Oncology Advances|January 4, 2021
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastomaCyrillo G Brahm, U Kulsoom Abdul, Megan Houweling, et al.
Neuro-Oncology Advances|January 4, 2021
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastomaTiffany G Baker, Jay Alden, Adrian M Dubuc, et al.
Neuro-Oncology Advances|November 1, 2019
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risksKay Ka-Wai Li, Zhi-Feng Shi, Tathiane M Malta, et al.
Neuro-Oncology Advances|March 3, 2020
Noninvasive quantification of SIRT1 expression-activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[18F]BzAHA PET/CT/MRIMaxwell T Laws, Robin E Bonomi, David J Gelovani, et al.
Pageof 138